Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly China To Double China Staff By End Of Year

This article was originally published in PharmAsia News

Executive Summary

Lilly China is ignoring the economic doldrums facing many firms and plans to double its current staff of 1,000 in China by the end of this year. Lilly China is among big pharma company in adding staff in China, with Novartis Pharmaceuticals planning a 20 percent per year staff increase until 2013. Lilly China President David Ricks said driving the staff increase is a need to add sales and distribution workers to enable the company to serve an expanded portion of the population. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel